|
|
Article: CORRECTION FROM SOURCE: Stellar Pharmaceuticals' Q3-2009 Financial Results Marked by Strong Growth and Continued Profitability.(Correction notice)
- Article from:
- Marketwire Canada
- Article date:
- November 10, 2009
CopyrightCOPYRIGHT 2009 Canadian Corporate News. News Provided by Comtex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LONDON, ONTARIO, Nov 10, 2009 (Marketwire via COMTEX) -- This release is to correct an inadvertent error in the press release issued on November 6, 2009 in which the Company's results for the quarter ended September 30, 2009, reported total revenues to only include product revenues and not total operating revenues from all sources. No other changes to the information contained in such report have been made. The corrected release follows:
Stellar Pharmaceuticals Inc. ("Stellar" or "the Company") (OTCBB:SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced its financial ...